Next-Generation Vaccines Based on Recombinant Proteins, Antibodies and Nucleic Acids
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Design, Development, and Delivery".
Deadline for manuscript submissions: 31 March 2027 | Viewed by 161
Special Issue Editors
Interests: infectious diseases; vaccines; formulation development; immunology; B-cells; SARS-CoV-2; influenza; microparticles; nanoparticles; microneedles; transdermal vaccines
Special Issues, Collections and Topics in MDPI journals
Interests: immunology; vaccinology; neutralizing antibodies; virology; protein engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of vaccinology is undergoing a profound transformation driven by advances in molecular engineering, structural biology, and nucleic acid technologies. This Special Issue, “Next-Generation Vaccines Based on Recombinant Proteins, Antibodies and Nucleic Acids,” highlights innovative strategies that are reshaping how we design and deliver vaccines and immunotherapies. Recombinant and monoclonal antibodies are enabling highly specific, customizable immune interventions, while protein-based vaccines continue to evolve through refined antigen design and principles of structural vaccinology. In parallel, mRNA and DNA platforms have opened new avenues for rapid, scalable, and adaptable therapeutics, expanding the possibilities for next‑generation immunization. Together, these approaches offer unprecedented precision in targeting infectious diseases, emerging pathogens, and even non‑communicable conditions.
This Special Issue welcomes cutting‑edge research and reviews that advance our understanding of these modalities and accelerate the development of safe, effective, and transformative vaccines and antibody‑based therapeutics.
Dr. Devyani Joshi
Dr. Sanjeev Kumar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoclonal antibodies
- recombinant scFv and nanobodies
- immunotherapies
- protein and nucleic acid based vaccines
- mRNA and DNA-based therapeutics
- next-generation immunization
- antigen design
- rational vaccine design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
